FHI vs AB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 07, 2026

FHI

31.7
AI Score
VS
AB Wins

AB

39.3
AI Score

Investment Advisor Scores

FHI

32score
Recommendation
EXTENDED

AB

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric FHI AB Winner
Forward P/E 10.9529 9.1491 AB
PEG Ratio 1.543 0.6343 AB
Revenue Growth 8.1% -40.3% FHI
Earnings Growth 11.9% -0.7% FHI
Tradestie Score 31.7/100 39.3/100 AB
Profit Margin 21.3% 0.0% FHI
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY FHI

Relative Price Performance (Last 90 Days)

FHI 1M: +14.4% · 3M: +1.3% AB 1M: -3.4% · 3M: -7.8%

Current Technical Phase

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 68.2 · Price: $63.99

AB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 38

RSI (14): 37.6 · Price: $34.09

Fundamentals Snapshot

Metric FHI AB
Market Cap — —
Forward P/E 10.7 9.2
Trailing P/E 11.9 10.4
Revenue (TTM) — —
Revenue Growth 0.1% -0.4%
Gross Margin 0.7% 1.0%
Operating Margin 0.3% 0.0%
EPS 5.39 3.37
Dividend Yield 0.02% 0.10%

Frequently Asked Questions

Based on our detailed analysis, AB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.